Streetbeat News

Products Services

MAR

Marriott International has entered into a strategic cooperation agreement with Delonix Group to expand the Tribute Portfolio brand in mainland China. The agreement could see over 100 Delonix hotels affiliate with Marriott's brand. This collaboration will allow the hotels to be booked through both companies' channels and loyalty programs, enhancing value for hotel owners and travel experiences for Chinese travelers. Delonix's portfolio includes over 1,400 hotels, with Grand New Century as a notable brand. Tribute Portfolio is a collection of over 100 independent hotels worldwide.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:05 pm

IGC

IGC Pharma, Inc. (NASDAQ:IGC) shares rose after announcing preclinical trial data for TGR-63, a drug candidate for Alzheimer's, showing significant plaque reduction. The company aims to move TGR-63 into human trials, inspired by the FDA's approval of similar drugs. The news resulted in heavy trading volume, with over 2.77 million shares traded compared to a 100-day average of under 204,000 shares.

Portfolio Pulse from Erica Kollmann

January 23, 2024 | 3:05 pm

ETAO

FAZE

JNJ

NUTX

NVVE

RVSN

VRM

U.S. stocks were mixed with the Dow Jones down and NASDAQ and S&P 500 up. Johnson & Johnson (JNJ) reported Q4 earnings that exceeded expectations with an 11.7% increase in adjusted EPS and a 7.3% rise in sales. FaZe Holdings (FAZE), Rail Vision (RVSN), and Nuvve Holding (NVVE) saw their stocks surge due to new deals and project wins. Vroom (VRM), Nutex Health (NUTX), and ETAO International (ETAO) experienced significant stock declines following negative business developments.

Portfolio Pulse from Avi Kapoor

January 23, 2024 | 3:04 pm

BA

Boeing is implementing a comprehensive plan to safely return its airplanes to service and enhance quality and delivery performance, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:04 pm

AAPL

QCOM

SSNLF

OnePlus has launched two new smartphones, the OnePlus 12 and OnePlus 12R, featuring Qualcomm's Snapdragon chipsets. The OnePlus 12 uses the Snapdragon 8 Gen 3 chipset and competes with Samsung's Galaxy S24 Ultra and Apple's iPhone 15 series, while the OnePlus 12R uses the older Snapdragon 8 Gen 2 chipset. The OnePlus 12 starts at $799 and the OnePlus 12R at $499, with sales starting on Feb 6 and Feb 13 respectively. The OnePlus 12 features a 6.82-inch Quad HD+ OLED display and supports 100W wired and 50W wireless charging, while the OnePlus 12R has a 6.78-inch Full HD+ OLED display and supports 100W wired charging.

Portfolio Pulse from Rounak Jain

January 23, 2024 | 3:03 pm

STLA

Stellantis CEO has expressed the company's potential to lead the global commercial vehicle market by 2030. The company has been in discussions with the Italian government for nine months, seeking support for EV sales via incentives and protection for the Mirafiori plant.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:03 pm

IAG

IAMGOLD Corporation reported its Q4 2023 production results, achieving 465,000 ounces of gold, at the top end of its annual guidance. Essakane and Westwood mines exceeded expectations, with Côté Gold commissioning on track for initial production in March 2024. The company will release full financial results on February 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:40 pm

DTSS

Datasea Inc. (NASDAQ:DTSS) pre-announced an estimated revenue of $18.2M for the first half of FY 2024, marking a significant increase of approximately 1,037.5% YoY. This growth is attributed to the success of their 5G messaging and Acoustic Intelligence businesses. However, these figures are preliminary and subject to change upon completion of standard closing procedures. The final financial statement is scheduled for release on February 14, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:36 pm

PFE

The National Institute for Health and Care Excellence (NICE) has recommended the use of talazoparib for treating advanced BRCA1/2-mutant, HER2– breast cancer. This recommendation could potentially increase the usage of talazoparib, which is a positive development for its manufacturer. Pfizer Inc. (PFE), the maker of talazoparib, may experience a positive impact on its stock as this recommendation could lead to increased sales of the drug.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:34 pm

NVEE

Nuvve Corporation has been awarded a $16 million project by the Fresno Economic Opportunities Commission (EOC) to electrify its 50-shuttle fleet with vehicle-to-grid capabilities. This initiative is part of Fresno EOC's efforts to promote cleaner transportation and environmental sustainability in the community.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:31 pm